These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4025111)

  • 1. The effect of bretylium and clofilium on dispersion of refractoriness and vulnerability to ventricular fibrillation in the ischemic feline heart.
    Kowey PR; Friehling TD; O'Connor KM; Wetstein L; Kelliher GJ
    Am Heart J; 1985 Aug; 110(2):363-70. PubMed ID: 4025111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of the effect of bretylium on the ventricular fibrillation threshold in dogs.
    Euler DE; Scanlon PJ
    Am J Cardiol; 1985 May; 55(11):1396-401. PubMed ID: 3993577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiologic effects of bretylium tosylate on the canine heart during coronary artery occlusion and reperfusion.
    Gibson JK; Stewart JR; Li YP; Lucchesi BR
    J Cardiovasc Pharmacol; 1983; 5(4):517-24. PubMed ID: 6193345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of bretylium tosylate on inhomogeneity of refractoriness and ventricular fibrillation threshold in canine hearts with quinidine-induced long QT interval.
    Inoue H; Toda I; Nozaki A; Matsuo H; Sugimoto T
    Cardiovasc Res; 1985 Oct; 19(10):655-60. PubMed ID: 4053141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation.
    Euler DE; Zeman TW; Wallock ME; Scanlon PJ
    Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemia-induced conduction delay and ventricular arrhythmias: comparative electropharmacology of bethanidine sulfate and bretylium tosylate.
    Kabell G
    J Cardiovasc Pharmacol; 1989 Mar; 13(3):471-82. PubMed ID: 2471895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of beta-adrenergic blockade on vulnerability to ventricular fibrillation and inducibility of ventricular arrhythmia in short- and long-term feline infarction models.
    Luketich J; Friehling TD; O'Connor KM; Kowey PR
    Am Heart J; 1989 Aug; 118(2):265-71. PubMed ID: 2750648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The antiarrhythmic and antifibrillatory actions of bretylium and its o-iodobenzyl trimethylammonium analog, UM-360.
    Kniffen FJ; Lomas TE; Counsell RE; Lucchesi BR
    J Pharmacol Exp Ther; 1975 Jan; 192(1):120-8. PubMed ID: 1123718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thromboxane synthetase inhibition on vulnerability to ventricular arrhythmia following coronary occlusion.
    O'Connor KM; Friehling TD; Kelliher GJ; MacNab MW; Wetstein L; Kowey PR
    Am Heart J; 1986 Apr; 111(4):683-8. PubMed ID: 3953390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrophysiologic effects of bretylium on canine ventricular muscle during acute ischemia and reperfusion.
    Fujimoto T; Hamamoto H; Peter T; McCullen A; McCullen A; Melvin N; Mandel WJ
    Am Heart J; 1983 Jun; 105(6):966-72. PubMed ID: 6858845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death.
    Holland K; Patterson E; Lucchesi BR
    Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrillatory action of bretylium: role of the sympathetic nervous system.
    Kopia GA; Lucchesi BR
    Pharmacology; 1987; 34(1):37-47. PubMed ID: 3575413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic and electrophysiologic actions of clofilium in experimental canine models.
    Kopia GA; Eller BT; Patterson E; Shea MJ; Lucchesi BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):49-61. PubMed ID: 4054216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bretylium tosylate: profile of the only available class III antiarrhythmic agent.
    Anderson JL
    Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental and clinical pharmacology of bretylium tosylate in acute myocardial infarction: a 15-year journey.
    Puddu PE; Jouve R; Saadjian A; Torresani J
    J Pharmacol; 1986; 17(3):223-43. PubMed ID: 3795968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bretylium on cardiovascular changes induced by coronary occlusion in the cat.
    Corr PB; Gillis RA
    Eur J Pharmacol; 1975; 33(2):401-4. PubMed ID: 1183484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the adrenergic nerve terminal in digitalis-induced cardiac toxicity: a study of the effects of pharmacological and surgical denervation.
    Lathers CM; Gerard-Ciminera JL; Baskin SI; Krusz JC; Kelliher GJ; Goldberg PB; Roberts J
    J Cardiovasc Pharmacol; 1982; 4(1):91-8. PubMed ID: 6176806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A method for quantitating antifibrillatory effects of drugs after coronary reperfusion in dogs: improved outcome with bretylium.
    Wenger TL; Lederman S; Starmer CF; Brown T; Strauss HC
    Circulation; 1984 Jan; 69(1):142-8. PubMed ID: 6689638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of newer antiarrhythmic drugs on defibrillation threshold.
    Tacker WA; Niebauer MJ; Babbs CF; Combs WJ; Hahn BM; Barker MA; Seipel JF; Bourland JD; Geddes LA
    Crit Care Med; 1980 Mar; 8(3):177-80. PubMed ID: 7363635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of ventricular fibrillation and positive inotropic action of bethanidine sulfate, a chemical analog of bretylium tosylate that is well absorbed orally.
    Bacaner MB; Hoey MF; Macres MG
    Am J Cardiol; 1982 Jan; 49(1):45-55. PubMed ID: 7053610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.